HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Multimodality imaging of coiled-coil mediated self-assembly in a "drug-free" therapeutic system.

Abstract
Two complementary coiled-coil peptides CCE/CCK are used to develop a "drug free" therapeutic system, which can specifically kill cancer cells without a drug. CCE is attached to the Fab' fragment of anti-CD20 1F5 antibody (Fab'-CCE), and CCK is conjugated in multiple grafts to poly[N-(2-hydroxypropyl)methacrylamide] (P-(CCK)x ). Two conjugates are consecutively administered: First, Fab'-CCE coats peptide CCE at CD20 antigen of lymphoma cell surface; second, CCE/CCK biorecognition between Fab'-CCE and P-(CCK)x leads to coiled-coil formation, CD20 crosslinking, membrane reorganization, and ultimately cell apoptosis. To prove that two conjugates can assemble at cell surface, multiple fluorescence imaging studies are performed, including 2-channel FMT, 3D confocal microscopy, and 4-color FACS. Confocal microscopy shows colocalization of two fluorescently labeled conjugates on non-Hodgkin's lymphoma (NHL) Raji cell surface, indicating "two-step" targeting specificity. The fluorescent images also reveal that these two conjugates can disrupt normal membrane lipid distribution and form lipid raft clusters, leading to cancer cell apoptosis. This "two-step" biorecognition capacity is further demonstrated in a NHL xenograft model, using fluorescent images at whole-body, tissue and cell levels. It is also found that delaying injection of P-(CCK)x can significantly enhance targeting efficacy. This high-specificity therapeutics provide a safe option to treat NHL and other B cell malignancies.
AuthorsRui Zhang, Jiyuan Yang, Te-Wei Chu, Jonathan M Hartley, Jindřich Kopeček
JournalAdvanced healthcare materials (Adv Healthc Mater) Vol. 4 Issue 7 Pg. 1054-65 (May 2015) ISSN: 2192-2659 [Electronic] Germany
PMID25612325 (Publication Type: Journal Article, Research Support, N.I.H., Extramural)
Copyright© 2015 WILEY-VCH Verlag GmbH & Co. KGaA, Weinheim.
Chemical References
  • Acrylamides
  • Antigens, CD20
  • Immunoglobulin Fab Fragments
  • Lipids
  • Membrane Lipids
  • Peptides
  • N-(2-hydroxypropyl)methacrylamide
Topics
  • Acrylamides (immunology)
  • Animals
  • Antigens, CD20 (immunology)
  • Apoptosis (drug effects, immunology)
  • Cell Line, Tumor
  • Female
  • Fluorescence
  • Humans
  • Immunoglobulin Fab Fragments (immunology)
  • Lipids (immunology)
  • Lymphoma (drug therapy, immunology)
  • Membrane Lipids (immunology)
  • Mice, Nude
  • Mice, SCID
  • Multimodal Imaging (methods)
  • Peptides (immunology, therapeutic use)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: